Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Glaukos Corp (GKOS)

Glaukos Corp (GKOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Glaukos Announces the Release of its 2025 Sustainability Report Business Wire - Thu Apr 16, 6:00AM CDT

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced...

GKOS : 121.48 (+0.50%)
Glaukos Receives Permanent J-code for Epioxa™ Business Wire - Wed Apr 15, 3:05PM CDT

New J-code for Epioxa ™ , J2789, set to become effective July 1, 2026

GKOS : 121.48 (+0.50%)
Glaukos to Release First Quarter 2026 Financial Results after Market Close on April 29 Business Wire - Wed Apr 8, 6:00AM CDT

Conference Call and Webcast Scheduled for 1:30 p.m. PT

GKOS : 121.48 (+0.50%)
Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting Business Wire - Mon Apr 6, 6:00AM CDT

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, announced...

GKOS : 121.48 (+0.50%)
Glaukos Announces Commercial Availability of Epioxa™, a Transformative Innovation in Interventional Keratoconus Care Business Wire - Thu Mar 19, 6:00AM CDT

Epioxa Provides the Ophthalmic Community and Patients with the First and Only FDA-Approved, Incision-Free, Topical Drug Therapy for Keratoconus, a Sight-Threatening Rare Disease

GKOS : 121.48 (+0.50%)
Glaukos: Q4 Earnings Snapshot AP - Tue Feb 17, 3:44PM CST

Glaukos: Q4 Earnings Snapshot

GKOS : 121.48 (+0.50%)
Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results Business Wire - Tue Feb 17, 3:05PM CST

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced...

GKOS : 121.48 (+0.50%)
Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose® TR Business Wire - Wed Jan 28, 6:00AM CST

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced...

GKOS : 121.48 (+0.50%)
Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17 Business Wire - Tue Jan 20, 6:00AM CST

Conference Call and Webcast Scheduled for 1:30 p.m. PT

GKOS : 121.48 (+0.50%)
NASDAQ sign at times square at night by Lucky-photographer via iStock
Stock Indexes Settle Lower on Tech Weakness Barchart - Wed Jan 14, 3:39PM CST

The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -0.53%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.07%. March...

MSTR : 171.02 (-0.84%)
GOOGL : 344.40 (+1.63%)
MPC : 224.14 (+1.37%)
GLXY : 26.00 (-1.05%)
RIVN : 16.52 (-2.54%)
ABNB : 142.82 (+0.67%)
COIN : 199.77 (+0.93%)
TGTX : 36.62 (-0.81%)
OXY : 57.12 (-1.23%)
TSLA : 376.30 (+0.69%)
^BTCUSD : 78,076.22 (+0.42%)
SPY : 713.94 (+0.77%)

Barchart Exclusives

Dan Ives: Tesla Is ‘Morphing into a Physical AI Stalwart’ So Don’t Sweat the CapEx and Just Buy TSLA Stock Barchart - Sat Apr 25, 11:00AM CDT
Wedbush’s Dan Ives is bullish on Tesla despite its increasing CapEx. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.